Dr. Lowell Anthony Use of Telotristat Epitrate in Patients with Carcinoid Syndrome

Overview of NETs; Lowell Anthony, MD, University of KentuckyПодробнее

Dr. Lowell Anthony: Use of Telotristat Etiprate in Patients with Carcinoid SyndromeПодробнее

COVID-19: Your Health & Safety with Lowell Anthony, MDПодробнее

Dr. Lowell Anthony on Targeted Therapy Associated DiarrheaПодробнее

Lowell Anthony, MD - UK HealthCareПодробнее

Dr. Anthony on Sequencing Strategies for Patients With NETsПодробнее

Dr. Anthony on the Pathology of Neuroendocrine TumorsПодробнее

Dr. Anthony on Treatment Benefit With Telotristat Epitrate in Patients With Carcinoid SyndromeПодробнее

Telotristat in the management of NET-related carcinoid syndrome diarrheaПодробнее

Dr. Pommier Discusses Challenges Associated With the Treatment of Carcinoid SyndromeПодробнее

Carcinoid Drug Offers Biggest Advance in Over a Decade Says Lexicon CEOПодробнее

Nurses are Vital to the Management of Carcinoid SyndromeПодробнее

Neuroendocrine tumours (NETs): What is carcinoid syndrome?Подробнее

Dr. Lowell Anthony Discusses Preventing Targeted Therapy-Associated DiarrheaПодробнее

The Role of Biomarkers in Neuroendocrine TumorsПодробнее

Wolin 2018: Treating NETs & Carcinoid Syndrome With Somatostatin Analogs (SSA)Подробнее

Gallstone ileusПодробнее

Novel Neuroendocrine Tumor (NET) TherapiesПодробнее

Dr Lapuerta Explains Carcinoid SyndromeПодробнее